Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Bioventus (BVS) Return on Equity (2021 - 2025)

Bioventus' Return on Equity history spans 4 years, with the latest figure at 0.16% for Q4 2025.

  • For Q4 2025, Return on Equity changed N/A year-over-year to 0.16%; the TTM value through Dec 2025 reached 0.16%, changed N/A, while the annual FY2023 figure was 0.24%, 10.0% down from the prior year.
  • Return on Equity reached 0.16% in Q4 2025 per BVS's latest filing, up from 0.05% in the prior quarter.
  • In the past five years, Return on Equity ranged from a high of 0.16% in Q2 2021 to a low of 0.6% in Q3 2023.
  • Average Return on Equity over 4 years is 0.09%, with a median of 0.01% recorded in 2022.
  • Peak YoY movement for Return on Equity: dropped -11bps in 2022, then crashed -60bps in 2023.
  • A 4-year view of Return on Equity shows it stood at 0.03% in 2021, then plummeted by -683bps to 0.16% in 2022, then tumbled by -109bps to 0.33% in 2023, then soared by 147bps to 0.16% in 2025.
  • Per Business Quant, the three most recent readings for BVS's Return on Equity are 0.16% (Q4 2025), 0.05% (Q3 2025), and 0.03% (Q2 2025).